HCLTECH
17.1.2024 10:31:27 CET | Business Wire | Press release
HCLTech, a leading global technology company, has emerged as the fastest-growing IT services brand with +15.9% YoY growth in brand value among the top 10 IT companies globally, as per the 2024 Brand Finance Global 500 and IT Services Top 25 Report released today in Davos.
Brand Finance, a leading independent brand valuation and strategy consultancy, adopted a methodology that evaluates a brand's strength based on its investments in marketing and brand initiatives, client and employee perception, and overall business performance. These findings come on the heels of HCLTech's strategic brand transformation efforts initiated 15 months ago. Led by a new brand identity and positioning, these efforts are anchored around Supercharging Progress™ and the company’s refreshed purpose - To bring together the best of technology and our people to supercharge progress.
Commenting on the update, Jill Kouri, Global CMO of HCLTech, said: "HCLTech’s business performance has surpassed the market across various key metrics. Our brand has been an important accelerator of this journey, helping reinforce our differentiation, further strengthen client and employee loyalty, showcase our abiding commitment to sustainability and CSR, and make it easier to connect with prospective clients in emerging markets. It is fulfilling to see our efforts recognized in the Brand Finance report.”
David Haigh, CEO of Brand Finance, highlighted: "We are highly impressed with the rapid and resilient increase in HCLTech's brand value and accelerated growth trajectory over the past few years. HCLTech stands out in terms of brand performance, excelling in both volume growth and the ability to drive profitability. This performance indicates a strong engagement with clients and an ability to capitalize on emerging market potential ahead of peer brands in the industry."
Over the last three decades, HCLTech has evolved as a leading global tech company offering a comprehensive portfolio encompassing digital, engineering, cloud, AI and software capabilities, which empowers clients in navigating end-to-end digital transformation. Fuelled by its holistic portfolio, core engineering DNA and decades of operational experience in AI, HCLTech stands at the pole position to unlock the best value from GenAI for its clients worldwide.
"The past year has been an exhilarating journey for our brand with a rejuvenated brand identity and positioning brought to life through best-in-class campaigns and platforms as well as through the actions, culture and values exhibited by our strong crew of over 224,000 HCLTechies who are our brand ambassadors. We are building on this momentum with strongly differentiated go-to-market campaigns this year,” said Zulfia Nafees, Global Head of Brand, HCLTech.
*Note for the Editors:
Top 10 IT Services providers as per Brand Finance Global 500 and IT Services Top 25 report are (in alphabetical order) -- Accenture, Capgemini, Cognizant, Fujitsu (IT Services), HCLTech, IBM Consulting, Infosys, NTT DATA, TCS, Wipro.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240116270482/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology29.10.2026 13:00:00 CET | Press release
Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response Parse Biosciences, the leading provider of scalable and accessible single-cell sequencing and a QIAGEN company, and Nomic Bio, a leader in high throughput proteomic profiling, today announced their partnership to generate Cascade, a 100 Million cell foundational dataset to understand the human immune response. The dataset's scale and depth will give pharma partners cellular- and protein-level insight into immune biology, accelerating their ability to identify and validate new drug targets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261029559438/en/ Cascade has already drawn foundational partner commitments from leading pharmaceutical and biotechnology companies, including GSK, Pfizer, Sanofi, Graph Therapeutics, and Turbine, underscoring the demand for large-scale, multimodal immune data in drug
CSC Named Winner of the Top InfoSec Innovator Award for Most Innovative DNS Security29.10.2026 13:00:00 CET | Press release
CSC’s Subdomain Monitoring recognized for innovation in mitigating subdomain hijacking risks from dangling DNS CSC, an enterprise-class domain registrar and world leader in mitigating brand, fraud, domain, and Domain Name System (DNS) threats, today announced that its Subdomain Monitoring solution took top honors for Most Innovative DNS Security in Cyber Defense Magazine’s 2026 Top InfoSec Innovator Awards. CSC introduced Subdomain Monitoring after analyzing close to half a million DNS records and finding that many companies were exposed to subdomain takeovers due to dangling DNS. CSC’s solution helps enterprises reduce this risk and secure their online ecosystems. It was the first and only technology on the market to ease the burden of tracking and maintaining DNS records and purging unused zone records to prevent subdomain hijacking. Subdomain Monitoring, powered by CSC’s one-of-a-kind DomainSecSM threat intelligence platform, alerts DNS administrators and security engineers when it
Two Single-Pill Triple Combination Lipid-Lowering Therapy Applications Validated in The European Union29.10.2026 12:27:00 CET | Press release
EMA has validated two marketing authorization applications from Daiichi Sankyo in the EU for single-pill triple-combinations of established lipid-lowering agents: bempedoic acid, ezetimibe, and either atorvastatin or rosuvastatin If approved, the proposed therapies could be the first oral single-pill triple-combinations for lipid-lowering in the EU, aiming to simplify treatment for patients requiring multiple lipid-lowering agents The submissions reflect the commitment of Daiichi Sankyo to addressing unmet needs in cardiovascular disease The European Medicines Agency (EMA) has validated two marketing authorization applications (MAA) from Daiichi Sankyo (TSE: 4568) for oral, single-pill triple-combination therapies. The applications seek approval for the treatment of adults with primary hypercholesterolemia or mixed dyslipidemia to reduce low-density lipoprotein cholesterol (LDL-C) levels and cardiovascular (CV) risk. Despite the availability of effective therapies, treatment discontinu
NIQ and Google Partner to Advance Agentic Commerce29.10.2026 11:45:00 CET | Press release
Built with Google Cloud and Gemini for business, NIQ and Google commit to transforming AI-driven product discovery, availability, and measurement Today, NielsenIQ (NYSE: NIQ) and Google announced a broad collaboration to advance agentic commerce, aiming to bring NIQ’s global retail and product intelligence together with Google’s AI commerce ecosystem to improve product discovery and local availability. NIQ and Google are looking to complement Google's extensive Shopping Graph of more than 60 billion product listings with NIQ’s Commerce Intelligence. NIQ is also naming Google Cloud as a primary AI and cloud services provider, and plans to deploy Gemini for business across its global workforce. As AI evolves from helping consumers discover products to recommending and purchasing them, brands and retailers increasingly rely on trusted product information, real-world availability, and measurement. The partnership is designed to help make agentic commerce even more reliable and measurable,
TradeStation Europe Expands Options Capability, Including Extended-Hours Trading29.10.2026 11:43:00 CET | Press release
Expanded intraday and options trading capability, combined with lower options and equities commissions across the Netherlands and the EEA TradeStation Europe B.V. (“TradeStation Europe”), the recently licensed European brokerage subsidiary of TradeStation Group, Inc. (“TradeStation”), today announced a round of product updates, including extended-hours options trading, along with reduced options and equities pricing, new single-stock option spreads and expanded intraday trading to enhance the offering for retail and institutional traders across the Netherlands and the European Economic Area (EEA). Extended-hours options trading is now live. Clients can trade eligible equity options during a pre-market session from 7:30 a.m. to 9:25 a.m. ET and an extended curb session from 4:00 p.m. to 4:15 p.m. ET. The launch follows Cboe Global Markets, Inc.’s (Cboe: CBOE) introduction of extended trading hours for options on 24 individual stocks and five ETFs, expanding access to some of the most ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom